Abstract
Introduction Trauma life support training programmes aim to improve trauma outcomes but there is no evidence from controlled trials to show that they work. We conducted a pilot study to assess the feasibility of conducting a cluster randomised controlled trial comparing the effect of Advanced Trauma Life Support® (ATLS®) and Primary Trauma Care (PTC) with standard care on patient outcomes.
Methods and analysis We piloted a pragmatic three-armed parallel, cluster randomised, controlled trial in tertiary care hospitals across metropolitan areas in India. We included adult trauma patients and residents managing these patients. Two hospitals were randomised to ATLS®, two to PTC, and three to standard care. The feasibility outcomes were consent rate, lost to follow up rate, pass rate, missing data rates, and differences in distribution between observed and data extracted from medical records. We conducted community consultations in parallel with the pilot trial.
Ethics and dissemination We obtained ethical approval from all participating hospitals.
Results Between April 2022 and February 2023 we included 376 patients and 21 residents. The percentage of patients who consented to follow up was 77% and the percentage of residents who consented to training was 100%. The lost to follow up rate was 14%. The pass rate was 100%. The missing data rate ranged from 0 to 98. Data collected through observations were similar to data extracted from medical records, but there was more missing data in the extracted data.
Conclusions Conducting a full-scale cluster randomised controlled trial comparing the effects of ATLS®, PTC, and standard care on patient outcomes should be feasible after incorporating key lessons from this pilot.
Competing Interest Statement
Several members of the Trauma life support training Effectiveness Research Network are ATLS and/or PTC instructors.
Clinical Trial
NCT05417243
Clinical Protocols
https://doi.org/10.1136/bmjopen-2021-057504
Funding Statement
Doctors for You through grants awarded to Karolinska Institutet by the Swedish Research Council (grant number 2020-03779) and the Laerdal Foundation (grant number 2021-0048).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The ethical approval numbers were IEC(II)/OUT/134/2022 for King Edward Memorial Seth G. S. Medical College and K.E.M. Hospital, Mumbai; IEC/214/22 for Lokmanya Tilak Municipal Medical College and General Hospital, Mumbai; HBTMC/266/SURGERY for HBT Medical College And Dr. R N Cooper Municipal General Hospital, Mumbai; CREC/2022/FEB/1(ii) for Medica Super-specialty Hospital, Kolkata; Medical College Kolkata, Kolkata; NRSmC/IEC/93/2021 for Sir Nil Ra-tan Sircar Medical College & Hospital, Kolkata; and PGI/IEC/2022/000/003 for Postgraduate Insti-tute of Medical Education & Research, Chandigarh.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Trauma life support training Effectiveness Research Network (TERN) collaborators
Trial registration This pilot study was registered with ClinicalTrials.gov (reg. no NCT05417243).
Role of study sponsor and funders: The funding sources had no role in the design of this study nor during its execution, analyses, interpretation of the data, or decision to submit the results.
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
